Characteristics | No (N = 170) | n (%) |
---|---|---|
Cancer Diagnosis | ||
-Breast cancer | 37 | 21.76% |
-Pancreatic cancer | 17 | 10.00% |
-Prostate cancer | 17 | 10.00% |
-Gastric cancer | 13 | 7.65% |
-Lung cancer | 12 | 7.06% |
-Colorectal cancer | 11 | 6.47% |
-Bladder cancer | 10 | 5.88% |
-Head and neck cancer | 10 | 5.88% |
-Liver cancer | 8 | 4.71% |
-Other | 35 | 20.59% |
Clinical stage | ||
-Stage I | 54 | 31.76% |
-Stage II | 54 | 31.76% |
-Stage III | 46 | 27.06% |
-Stage IV | 16 | 9.41% |
Time since diagnosis (months) ** | 12 (IQR: 1-156) | |
Comorbidities | ||
-None | 129 | 75.88% |
-Diabetes | 12 | 7.06% |
-Respiratory diseases | 3 | 1.76% |
-Hypertension | 8 | 4.71% |
-Other | 18 | 10.59% |